<DOC>
	<DOCNO>NCT00743522</DOCNO>
	<brief_summary>Although shock therapy effective terminate ventricular tachycardia ( VT ) , painful patient repetitive shock decrease patient 's quality life . Previous study suggest one set aggressive device parameter setting may reduce total number shock primary prevention patient . In addition shock therapy , antitachycardia pacing ( ATP ) also available ICDs treat VT . The PROVIDE trial aim prospectively study effect high detection rate , prolonged detection interval , aggressive SVT discriminator , extensive ATP therapy prolonging time first shock primary prevention patient .</brief_summary>
	<brief_title>Programming Implantable Cardioverter Defibrillators Patients With Primary Prevention Indication</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<criteria>Primary Prevention indication ICD/ CRTD No prior document history spontaneous VT/VF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Reducing shock</keyword>
</DOC>